Mahdi Barzegar

10PUBLICATIONS
29CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersPacific Peoples epidemiologyNeurology and neuromuscular diseasesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2025
Comorbidity and cardiovascular risk factors in multiple sclerosis.

Mahdi Barzegar, Sara Samadzadeh, Kosar Kohandel

|Oct 03, 2022
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis.

Mahdi Barzegar, Shakiba Houshi, Erfan Sadeghi

|Mar 01, 2022
Bell's palsy after Sputnik V COVID-19 (Gam-COVID-Vac) vaccination.

Omid Mirmosayyeb, Mahdi Barzegar, Mina Rezaei

|Feb 15, 2022
Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset.

Dena Sadeghi-Bahmani, Mahdi Barzegar, Omid Mirmosayyeb

|Dec 20, 2021
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica.

Milad Moayednia, Leila Dehghani, Amir Safi

|Aug 02, 2021
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Nasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar

Pageof 2

Frequent Collaborators

6 joint publications

Omid Mirmosayyeb

4 joint publications

Vahid Shaygannejad

3 joint publications

Nasim Nehzat

2 joint publications

Dena Sadeghi-Bahmani